Previous Close | 0.0500 |
Open | 0.0400 |
Bid | 0.0250 x N/A |
Ask | 0.0500 x N/A |
Day's Range | 0.0400 - 0.0400 |
52 Week Range | 0.0100 - 0.4400 |
Volume | |
Avg. Volume | 75,998 |
Market Cap | 3.415M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1260 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Growth Strategist Veteran Joins Plantable To Boost Business Growth New York, New York--(Newsfile Corp. - June 2, 2022) - Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the "Company") today announces it has finalized its senior management team with the hiring of James (Jim) Wachtel as Chief Growth Officer (CGO) effective June 2, 2022. Jim will lead all new business growth, adding to the Company's aggressive growth strategy, with a primary responsibility of driving ...
New York, New York--(Newsfile Corp. - May 13, 2022) - Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the "Company"), a clinically supported dietary intervention program to reverse and prevent chronic disease, today announced the financial results for the three months ended March 31, 2022.The quarter end consolidated interim financial statements were prepared in accordance with the International Accounting Standards ("IAS") 34, Interim Financial Reporting, under International F
New York, New York--(Newsfile Corp. - May 10, 2022) - Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the "Company") announces that its common shares have been successfully upgraded to trade on the OTCQB® Venture Market (the "OTCQB") under the symbol "PLBLF" and now are eligible for electronic clearing and settlement through the Depository Trust Company ("DTC") in the United States; effective at the open of trading on May 9, 2022. The Company's ...